(Q39783457)

14 September 2017

title

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (English)

1 reference

14 September 2017

0 references

0 references

1 reference

1 reference

parkinsonian syndrome

1 reference

5

Claudia Trenkwalder

1 reference

14 September 2017

Friederike Sixel-Döring

4

Friederike Sixel-Döring

1 reference

14 September 2017

Michael G Schlossmacher

Michael G Schlossmacher

6

0 references

Brit Mollenhauer

1

Brit Mollenhauer

1 reference

Walter J Schulz-Schaeffer

14 September 2017

3

Walter Schulz-Schaeffer

1 reference

14 September 2017

Joseph J Locascio

2

1 reference

14 September 2017

publication date

1 March 2011

1 reference

14 September 2017

1 reference

14 September 2017

volume

10

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

230-240

1 reference

Genome-wide association study reveals genetic risk underlying Parkinson's disease

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Does corticobasal degeneration exist? A clinicopathological re-evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Imaging Dopamine Transporters in Parkinson‘s Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Biomarker research in Parkinson's disease: objective measures needed for patient stratification in future cause-directed trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Accuracy in the clinical diagnosis of parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Second consensus statement on the diagnosis of multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

1 reference

7 January 2021

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Levodopa for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Multiple system atrophy: a primary oligodendrogliopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Biomarkers in Parkinson‘s Disease: A Funder‘s Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970014-X

7 January 2021

10.1016/S1474-4422(11)70014-X

Identifiers

DOI

1 reference

14 September 2017

1 reference